Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey

dc.contributor.authorBogdanet, Delia
dc.contributor.authorEgan, Aoife M.
dc.contributor.authorFhelelboom, Narjes
dc.contributor.authorBiesty, Linda M.
dc.contributor.authorThangaratinam, Shakila
dc.contributor.authorDempsey, Eugene M.
dc.contributor.authorCrowther, Caroline
dc.contributor.authorDevane, Declan
dc.contributor.authorDunne, Fidelma P.
dc.date.accessioned2019-05-16T15:26:53Z
dc.date.available2019-05-16T15:26:53Z
dc.date.issued2019-01-05
dc.description.abstractGestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours. Despite this high risk of additional comorbidities, there is no standardised approach to the long-term follow-up of women with a previous diagnosis of GDM. Also, there is no standardisation of outcome selection and reporting in studies involving this population. This increases the risk of reporting bias and reduces the possibility of meaningful comparisons between studies. The aim of this study is to develop a protocol for a core outcome set (COS) for the metabolic follow-up at 1 year and beyond of women with previous GDM treated with insulin and/or oral hypoglycaemic agents.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleid9en
dc.identifier.citationBogdanet, D., Egan, A., Fhelelboom, N., Biesty, L., Thangaratinam, S., Dempsey, E., Crowther, C., Devane, D. and Dunne, F., 2019. Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey. Trials, 20(1).(7pp) DOI: 10.1186/s13063-018-3059-8en
dc.identifier.doi10.1186/s13063-018-3059-8en
dc.identifier.endpage7en
dc.identifier.issn1745-6215
dc.identifier.journaltitleTrialsen
dc.identifier.startpage1en
dc.identifier.urihttps://hdl.handle.net/10468/7927
dc.identifier.volume20en
dc.language.isoenen
dc.publisherSpringer Natureen
dc.relation.urihttps://trialsjournal.biomedcentral.com/articles/10.1186/s13063-018-3059-8
dc.rights© The Author(s). 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en
dc.subjectCore outcome seten
dc.subjectGestational diabetesen
dc.subjectInsulinen
dc.subjectOral hypoglycaemic agentsen
dc.titleMetabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi surveyen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
s13063-018-3059-8.pdf
Size:
713.96 KB
Format:
Adobe Portable Document Format
Description:
Published Version
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description: